Robert Zamboni

7.4k citations

110 papers · 4.2k indexed · 1 hit paper · h-index 35

Impact in

Organic Chemistry top 2%
- Asymmetric Synthesis and Catalysis
Physiology top 2%
- Asthma and respiratory diseases
- Alzheimer's disease research and treatments

Papers in

Organic Chemistry 38
- Carbohydrate Chemistry and Synthesis 9
- Synthetic Organic Chemistry Methods 7
Pharmaceutical Science 8
- Fluorine in Organic Chemistry 8

Co-authors: Joshua Rokach Donald W. Nicholson John P. Vaillancourt A. W. Ford‐Hutchinson Nancy A. Thornberry George S. Robertson Sophie Roy Daigen Xu
Journals: Bioorganic & Medicinal Chemistry Letters (23 papers)Tetrahedron Letters (12 papers)The Journal of Organic Chemistry (7 papers)Prostaglandins (6 papers)Journal of Biological Chemistry (6 papers)
Partner nations: Canada United States Greece

In The Last Decade

Robert Zamboni

110 papers receiving 4.0k citations

Hit Papers

align trajectories log scale

Involvement of Caspases in Proteolytic Cleavage of Alzheimer’s Amyloid-β Precursor Protein and Amyloidogenic Aβ Peptide Formation 1999 · 673 citations

Peers

Countries citing papers authored by Robert Zamboni

Since Specialization

Citations

This map shows the geographic impact of Robert Zamboni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Zamboni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Zamboni more than expected).

Fields of papers citing papers by Robert Zamboni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Zamboni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Zamboni. The network helps show where Robert Zamboni may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert Zamboni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert Zamboni Line = papers co-authored together Robert Zamboni links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Pathogenic mitochondrial dysfunction and metabolic abnormalities Biochemical Pharmacology ·Walter H. Moos, Douglas V. Faller, Ioannis P. Glavas, David N. Harpp, 贺兰云, Jeffrey W. Taliaferro, Krishna Kodukula, Anastasios Mavrakis, Barbara Machado Flores, Donald Yannascoli, Carl A. Pinkert, Whitney R. Powers, Kosta Steliou, Constantin Tamvakopoulos, Demetrios G. Vavvas, Robert Zamboni, Konstantina Sampani	2021	29
2	Epigenetic treatment of dermatologic disorders Drug Development Research ·Walter H. Moos, Douglas V. Faller, Ioannis P. Glavas, David N. Harpp, Jeffrey W. Taliaferro, Carl A. Pinkert, Whitney R. Powers, Konstantina Sampani, Kosta Steliou, Demetrios G. Vavvas, Krishna Kodukula, Robert Zamboni	2019	2
3	Discovery of ITX 4520: A highly potent orally bioavailable hepatitis C virus entry inhibitor Bioorganic & Medicinal Chemistry Letters ·Gopi Kumar Mittapalli, Fang Zhao, Andrew Jackson, Hongfeng Gao, Haekyung Lee, María Victoria Valerga Fernández, Maninder Kaur, Natalie Nguyen, Robert Zamboni, Amanda Perkins, Flossie Wong‐Staal, James E. Macdonald	2012	19
4	Design and synthesis of dipeptidyl nitriles as potent, selective, and reversible inhibitors of cathepsin C Bioorganic & Medicinal Chemistry Letters ·Daniel Guay, Christian Beaulieu, T. Jagadeeswar Reddy, Robert Zamboni, Nathalie Méthot, Joel Rubin, Diane Ethier, M. David Percival	2009	34
5	Photo-crosslinking of proteins in intact cells reveals a dimeric structure of cyclooxygenase-2 and an inhibitor-sensitive oligomeric structure of microsomal prostaglandin E2 synthase-1 Archives of Biochemistry and Biophysics ·Pierre‐Olivier Hétu, Marc Ouellet, Jean‐Pierre Falgueyret, Chidambaram Ramachandran, Joël Robichaud, Robert Zamboni, Denis Riendeau	2008	5
6	Metabolic activation of indole-containing prostaglandin D2 receptor 1 antagonists: Impacts of glutathione trapping and glucuronide conjugation on covalent binding Bioorganic & Medicinal Chemistry Letters ·Jean-François Lévesque, Stephen H. Day, Nathalie Chauret, Carmai Seto, Laird A. Trimble, Kevin P. Bateman, José M. Silva, Carl Berthelette, Nicolas Lachance, Michael J. Boyd, Lianhai Li, Claudio F. Sturino, Zhaoyin Wang, Robert Zamboni, Robert N. Young, Deborah A. Nicoll‐Griffith	2007	20
7	In vitro biotransformations of the prostaglandin D2 (DP) antagonist MK-0524 and synthesis of metabolites Bioorganic & Medicinal Chemistry Letters ·Deborah A. Nicoll‐Griffith, Carmai Seto, Yves Aubin, Li Deshan, Nathalie Chauret, Stephen H. Day, José M. Silva, Laird A. Trimble, Jean‐François Truchon, Carl Berthelette, Nicolas Lachance, Zhaoyin Wang, Claudio F. Sturino, JinSong Wang -, Robert Zamboni, Robert N. Young	2006	14
8	Identification of a potent and selective non-basic cathepsin K inhibitor Bioorganic & Medicinal Chemistry Letters ·Chun Sing Li, Denis Deschênes, Sylvie Desmarais, Jean‐Pierre Falgueyret, Jacques Yves Gauthier, Donald B. Kimmel, Serge Léger, Frédéric Massé, Mary E. McGrath, Daniel J. McKay, M. David Percival, Denis Riendeau, Sevgi B. Rodan, Michel Thérien, Yutao Ma, Gregg Wesolowski, Robert Zamboni, W. Cameron Black	2006	67
9	Novel pyrazinone mono-amides as potent and reversible caspase-3 inhibitors Bioorganic & Medicinal Chemistry Letters ·Yongxin Han, André Giroux, John Colucci, Christopher I. Bayly, Daniel J. McKay, Sophie Roy, Amer Mohioddin Shashi Kumar P Srinu, John P. Vaillancourt, Dita Rasper, John Tam, Paul Tawa, Donald W. Nicholson, Robert Zamboni	2005	25
10	Structure–activity relationship studies on ortho-substituted cinnamic acids, a new class of selective EP3 antagonists Bioorganic & Medicinal Chemistry Letters ·Michel Belley, Michel Gallant, Bruno Roy, Lowenstein Sandler Pc, Nicolas Lachance, Marc Labelle, Laird A. Trimble, Nathalie Chauret, Chun Li, Nicole Sawyer, Nathalie Tremblay, Sonia Lamontagne, Marie‐Claude Carrière, Danielle Denis, Gillian Greig, S. G. Skrypkin, Kathleen M. Metters, Robert J. Gordon, Chi Chung Chan, Robert Zamboni	2004	24
11	Synthesis of a novel peptidic photoaffinity probe for the PTP-1B enzyme Bioorganic & Medicinal Chemistry Letters ·Michel Thérien, Kathryn Skorey, Robert Zamboni, Chun Sing Li, Cheuk K. Lau, Tammy LeRiche, Vouy Linh Truong, Deena Waddleton, Chidambaram Ramachandran	2004	12
12	Solid phase synthesis of selective caspase-3 peptide inhibitors Bioorganic & Medicinal Chemistry ·Erich L. Grimm, Bruno Roy, Renée Aspiotis, Christopher I. Bayly, Donald W. Nicholson, Dita Rasper, Johanne Renaud, Sophie Roy, John Tam, Paul Tawa, John P. Vaillancourt, Steven Xanthoudakis, Robert Zamboni	2004	12
13	Differential Efficacy of Caspase Inhibitors on Apoptosis Markers during Sepsis in Rats and Implication for Fractional Inhibition Requirements for Therapeutics The Journal of Experimental Medicine ·Nathalie Méthot, Jingqi Huang, Nathalie Coulombe, John P. Vaillancourt, Dita Rasper, John Tam, Yongxin Han, John Colucci, Robert Zamboni, Steven Xanthoudakis, Sylvie Toulmond, Donald W. Nicholson, Sophie Roy	2004	49
14	3,6-Fluorescein Diphosphate: A Sensitive Fluorogenic and Chromogenic Substrate for Protein Tyrosine Phosphatases SLAS DISCOVERY ·Zheng Huang, Qingping Wang, Hoa D. Ly, Trevor Cai, John Scheigetz, Robert Zamboni, Sylvie Desmarais, Chidambaram Ramachandran	1999	43
15	Involvement of Caspases in Proteolytic Cleavage of Alzheimer’s Amyloid-β Precursor Protein and Amyloidogenic Aβ Peptide Formation Cell ·François G. Gervais, Daigen Xu, George S. Robertson, John P. Vaillancourt, Julia Sieß, Jingqi Huang, Andréa C. LeBlanc, David W. Smith, Michael Rigby, Mark S. Shearman, Earl E. Clarke, Hui Zheng, 龍子佐藤, Абдусаттар Ахатович Насиров, Nancy A. Thornberry, Amer Mohioddin Shashi Kumar P Srinu, Robert Zamboni, Sophie Roy, Donald W. Nicholson Hit paper breakdown →	1999	673
16	Substituted heterocyclic analogs as selective COX-2 inhibitors in the flosulide class Bioorganic & Medicinal Chemistry Letters ·Nathalie Ouimet, Chi-Chung Chan, S. Charleson, David Claveau, Robert J. Gordon, Daniel Guay, E.V. Gubanova, Marc Ouellet, D. Percival, Denis Riendeau, Elizabeth Wong, Robert Zamboni, Petpiboon Prasit	1999	20
17	Structural Characterization of the Covalent Attachment of Leukotriene A3to Leukotriene A4Hydrolase Archives of Biochemistry and Biophysics ·Joseph A. Mancini, Russell J. Waugh, John A. Thompson, Jilly F. Evans, Michel Belley, Robert Zamboni, Robert C. Murphy	1998	9
18	Photoaffinity labelling of human leukotriene C₄ synthase in THP‐1 cell membranes FEBS Letters ·Ambereen Ali, Robert Zamboni, Anthony W. Ford‐Hutchinson, Donald W. Nicholson	1993	2
19	In vitro and in vivo biotransformations of the potent leukotriene D4 antagonist verlukast in the rat. Drug Metabolism and Disposition ·Deborah A. Nicoll‐Griffith, James A. Yergey, Laird A. Trimble, H R Williams, Muhammad M Salameh, Robert Zamboni	1992	7
20	Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D₄ receptor antagonist Canadian Journal of Physiology and Pharmacology ·Thomas R. Jones, Robert Zamboni, Michel Belley, Éric Champion, L. Charette, A. W. Ford‐Hutchinson, Richard Frenette, Won Suek Cho, Serge Léger, P. Masson, C. S. McFarlane, Anaël Ohayon, Joshua Rokach, H R Williams, Robert N. Young, Robert N. DeHaven, Sheng‐Shung Pong	1989	232

About Robert Zamboni

Robert Zamboni is a scholar working on Organic Chemistry, Pharmaceutical Science, Biochemistry, Pharmacology and Physiology, having authored 110 papers that have together received 4.2k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (17 papers), Inflammatory mediators and NSAID effects (10 papers), Chemical Synthesis and Analysis (10 papers), Carbohydrate Chemistry and Synthesis (9 papers), Fluorine in Organic Chemistry (8 papers), Synthesis of Organic Compounds (8 papers), Cell death mechanisms and regulation (8 papers) and Synthetic Organic Chemistry Methods (7 papers). The work is most often cited by research in Organic Chemistry (1.2k citations), Physiology (989 citations), Biochemistry (267 citations), Pharmaceutical Science (194 citations) and Molecular Biology (2.0k citations). Robert Zamboni has collaborated with scholars based in Canada, United States and Greece. Frequent co-authors include Joshua Rokach, Donald W. Nicholson, John P. Vaillancourt, A. W. Ford‐Hutchinson, Nancy A. Thornberry, George S. Robertson, Sophie Roy, Daigen Xu, Dita Rasper and Michel Belley. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Tetrahedron Letters, The Journal of Organic Chemistry, Prostaglandins and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact